Educational information, not financial advice or a personal recommendation. Not regulated by the FCA. Do your own research. Capital at risk.

The Cooper Companies, Inc. (COO)

Healthcare BalancedS&P 500

The Cooper Companies is a global medical device business that helps people see better through contact lenses and supports women's reproductive health.

$53.91

Is The Cooper Companies, Inc. a good stock for a UK beginner?

The honest version: There's no rating here and nothing for sale. In its favour: Strong gross margins showing efficient product manufacturing. Worth weighing: Low net profit margin suggests high operating expenses.

No rating · no target price · nothing for sale here
Price-40.7%
= past earnings-report date
Priced in USD. As a UK investor your £ return also moves with the pound-to-dollar exchange rate, even inside an ISA - a stronger pound can trim your £ gains and a weaker pound can add to them, whatever the share price itself does.
52-week range+4% past year
$53.91
Low $53.91High $89.83
Where today's price sits versus its past year - context, not a signal.

Is this normal for this company?

Each figure against the range this same company has produced recently. Neither end of a range is the good end.

Price to earnings
11.7now
13.618.7

Share price divided by the earnings actually reported over the four most recent quarters. The range is the same calculation at each of this company's last few results, so roughly the past year.

Net profit margin
-7.2%now
-7.2%12.8%

Profit as a share of sales, from the company's own quarterly statements. The range covers the 5 quarters we hold, and the figure shown is its most recent one.

How these ranges are built

Every number here is the company's own reported figure, not a comparison with other companies. The ranges come from this company's own results and its share price. Where it reports in a different currency from the one its shares trade in, the price-to-earnings range is left out rather than mixing the two.

What does The Cooper Companies, Inc. do?

This company operates in two main areas: CooperVision, which makes contact lenses, and CooperSurgical, which provides tools for fertility and women's health. Revenue flows from selling these specialised medical products to eye care professionals and hospitals worldwide. Much comes down to how well they grow sales in these competitive healthcare markets while keeping their manufacturing costs under control.

On our factor screen it looks strongest on value and momentum, and weakest on income.

Quick checks
What's strong
What to watch
  • Income screens low

Does The Cooper Companies, Inc. pay a dividend?

No - The Cooper Companies, Inc. doesn't currently pay a dividend, so the whole return would rest on the share price. Plenty of growing companies reinvest their profits instead of paying them out - neither approach is better or worse, they're just different.

Most recent ex-dividend date: 26 Jul 2023. To receive a dividend you must already own the shares before the ex-dividend date; become a holder on or after it and the previous owner keeps that payment. Why the price usually falls that morning →

Does The Cooper Companies, Inc. have more cash or more debt?

It holds about $138.80M in cash against about $2.73B of debt - so it has net debt of about $2.59B. Debt is not automatically a problem - it funds growth - but it has to be serviced and repaid, which matters more when profits wobble.

From the latest reported balance sheet. Cash and debt levels change, and some borrowing is normal - this is context, not a judgment.

What do The Cooper Companies, Inc.'s numbers mean?

P/E
65.10
This shows how much investors are currently paying for every pound of the company's recent profit, reflecting high expectations for future growth.
Higher than most of the 60 Healthcare shares we cover
Forward P/E
15.38
This looks at the price compared to expected future profits, suggesting that analysts anticipate a significant jump in earnings over the coming year.
Around the middle of the 74 Healthcare shares we cover
Gross margin
65.6%
This indicates that for every pound of sales, the company keeps over 65 pence after paying for the direct costs of making their products.
Around the middle of the 74 Healthcare shares we cover
Beta
0.8
A number below 1.0 suggests the share price tends to be slightly less jumpy than the wider stock market.

How has it performed?

Growth of £1,000, the worst fall, and year by year
If you had put $1,000 into The Cooper Companies, Inc.
$593-41%

Over about 2 years to 2026-09-11. This is the share price only; any dividends would add to it. And it's the USD return - as a UK investor your actual £ return also moves with the exchange rate. Past performance is not a guide to the future, and it could just as easily have fallen.

How much has The Cooper Companies, Inc. actually fallen?

−52%

Over the last 2 years of daily prices, The Cooper Companies, Inc. fell as much as −52% from a high to a later low. Falls like this are normal when you own a share.

Past falls are not a forecast - it can fall further, or recover.

How has it done year by year?

2022-21%
2023+14%
2024-3%
2025-11%
2026 so far-6%

Calendar-year total return - the share price with dividends reinvested - from adjusted closing prices. The current year is only part-complete. Past returns are not a guide to the future.

A closer look at the numbers

Ownership, earnings history, where the money goes, and the outlook range
Market cap: The company's total value on the stock market - share price times the number of shares. Big = 'large-cap', small = 'small-cap'.
$14.98B
Avg volume: How many shares change hands on a typical day. Higher means it's easy to buy or exit without moving the price.
2.83M
Day range: The lowest and highest price the shares traded at during the latest day.
$53.15 – $55.63
52-week range: The lowest and highest the shares have traded over the past year - a sense of how wide the swings have been.
$58.89 – $89.83
P/E ratio: Price-to-earnings: the share price divided by yearly profit per share. Lower can mean cheaper; higher often means investors expect fast growth.
65.1
Beta: How bumpy the share price is versus the whole market. Above 1 swings more than the market; below 1 is calmer. It's about the ride, not whether it goes up or down.
0.82

Does the share price tell you if it's cheap or expensive?

One share costs$53.91
Number of shares278 million
So the whole company is worth$14.98bn
A £5 share is not cheaper than a £500 one - it means the company cut itself into more slices. Whether the total looks high or low is what the figures below are for; we don't give a verdict.
How bumpy is it?Beta: How bumpy the share price is versus the whole market. Above 1 swings more than the market; below 1 is calmer. It's about the ride, not whether it goes up or down. 0.82
Calm
Wild
Roughly in step with the market

Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.

Why has it been moving?▲ +2% past week · ▲ +4% past year

Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.

How much money does The Cooper Companies, Inc. make?

Revenue and profit by quarter, and how much of each sale turns into profit.

RevenueNet income
$0$270.38M$540.75M$811.12M$1.08BQ2 25Q3 25Q4 25Q1 26Q2 26
Gross margin
65.6%
Net margin
5.6%
Return on equity
2.9%

Where does each £100 of The Cooper Companies, Inc.'s sales go?

Making the product or service £34Running costs, tax and interest £60Left as profit £6

A rough split of the latest full-year figures: of every £100 of sales, about £34 covers making the product or service, £60 goes on running costs, tax and interest, and about £6 is left as profit. Margins vary a lot by industry, and one-off items can distort a single year.

When does The Cooper Companies, Inc. report earnings, and how did recent quarters go?

The Cooper Companies, Inc. is next scheduled to report on about 2026-12-10 - dates can move, and we don't predict results; this just tells you when to look.

‘Beat’ and ‘missed’ are against what analysts expected, not whether the business is doing well.

The Cooper Companies, Inc.: reported versus expected earnings per share, recent quarters
ReportedExpected EPS: The earnings per share analysts expected for the quarter - the average of their forecasts. 'Beating' or 'missing' is measured against this number.Actual EPSvs expected
2026-09-09$1.12$1.15Beat +3%
2026-06-04$1.09$1.21Beat +11%
2026-03-05$1.03$1.10Beat +7%
2025-12-04$1.11$1.15Beat +3%
2025-08-27$1.07$1.10Beat +3%
2025-05-29$0.93$0.96Beat +3%

Across the last 6 quarters here, The Cooper Companies, Inc. came in ahead of what analysts expected 6 times. One quarter is noise, not a trend.

See who else reports over the next two weeks →

Where these figures come from

Each quarter a company reports its results against a consensus of analyst forecasts. The figures here are reported versus expected earnings per share from published results; the expectation is that analyst consensus, not our view. Report dates are estimates and can move.

What are the scenarios for The Cooper Companies, Inc.?

An illustrative range for the year ahead — not a prediction or a price target.

◀ lowerhigher ▶todayBull▲ UpsideBase• In-lineBear▼ Downside
Bull
+5% to +10%Stronger than expected demand for new contact lens products.
Base
-2% to +2%Steady sales growth in line with historical trends.
Bear
-5% to -10%Supply chain disruptions slowing down product distribution.

What are the pros, cons and common questions?

The case each way, and the questions people ask
The bull case

Dominance in the growing global contact lens market.

The bear case

Long-term decline in healthcare spending or regulatory hurdles.

What are the pros and cons of The Cooper Companies, Inc.?

3bull points
6bear points

A balance check, not a score or verdict.

The bull case3
  • Strong gross margins showing efficient product manufacturing
  • Operates in essential healthcare sectors with steady demand
  • Lower volatility compared to the broader market
The catch3
  • Low net profit margin suggests high operating expenses
  • Does not pay a dividend to shareholders
  • Return on equity: How much profit the company makes for each £1 shareholders have put in. Higher usually means a more efficient business. is currently quite modest
Key risks3
  • Heavy reliance on the competitive contact lens market
  • Potential for regulatory changes in medical device approvals
  • Integration risks from past or future company acquisitions
What would flip the thesis

The write-up's own warning lights — if these start happening, the case above changes.

  • A sustained drop in revenue growth below 5%
  • A significant and permanent decline in gross margins

Common questions about The Cooper Companies, Inc.

Does The Cooper Companies, Inc. pay a dividend?

No - The Cooper Companies, Inc. does not currently pay a dividend, so the return would rest on the share price. Many growing companies reinvest profits instead of paying them out.

When does The Cooper Companies, Inc. report earnings next?

The Cooper Companies, Inc. is next scheduled to report results on about 2026-12-10. Report dates are estimates and can move; this is a diary note for when to look, not a forecast of the outcome.

More in Healthcare

Solventum CorporationIDEXX Laboratories, Inc.Charles River Laboratories International, Inc.Baxter International Inc.GSKHaleon plcAstraZeneca PLCConvatec Group PLC
Confidence: medium · data: USD · flags: earnings_growth · Charts by TradingView Lightweight Charts™
Found this useful? The Almanac is free and ad-free - a coffee keeps it that way.Support →

Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →

This plain-English summary was auto-generated on 2026-08-02 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.

Prices as of 11 Sep 2026; other figures as of 11 Aug 2026. Prices may be delayed and numbers can go stale - always double-check before acting.